Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Avonex approved by European Commission

March 18, 1997

Lanepitant not effective in migraine

March 18, 1997

Pharmacodynamics and safety of the dopamine agonist CI-1007

March 18, 1997

Topical anesthesia with liposome-encapsulated tetracaine

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Aricept cleared for marketing in U.K.

March 17, 1997

New therapy for essential tremor recommended for approval

March 17, 1997

SIB-1508Y associated with improvement in cognitive deficits in Parkinson's model

March 17, 1997

Repeated IVIg for relapsing-remitting MS

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...